Bruce Ratner, Adam Bonislawski

Early Detection (eBook, ePUB)

How America Can Win the War on Cancer

• Format: ePub

Produktbeschreibung

In an accessible yet fastidiously researched intervention Early Detection sets out the urgent necessity of fundamentally re-directing the US's approach to cancer treatment if President Biden's recently announced prioritization of the issue is to be successful.



Catching cancer early remains the single best approach to fighting this deadly disease, the second-leading killer both in the US and worldwide. Yet, the health system often fails to do so, even when the necessary tools are available. Early Detection looks at shortcomings in cancer screening efforts and how early detection procedures can be expanded and improved..



Early Detection explores cancer screening systematically and scientifically, examining the subject from the level of individual tests all the way up to the roles and incentives of large healthcare systems and the federal government. It looks not only at the scientific challenges involved but also the social and organizational challenges, an angle that has been traditionally under-covered but is especially relevant in light of the COVID-19 pandemic.



The book also highlights the disparities of race and economic class that affect access to early screening. This problem exists throughout the medical system overall but, when it comes to early detection, the problem becomes especially far-reaching from both an ethical and an economic point of view.



In teaming together, Bruce Ratner and Adam Bonislawski combine the passions of someone touched deeply by the experience of cancer and the cool analysis of an expert in medical policy and science. They tackle the subject with a combination of breadth and granularity, exploring why early detection has not been given the level of priority it deserves, and the ways it can dramatically reduce cancer deaths in this country.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, D ausgeliefert werden.

Produktdetails

• Verlag: OR Books
• Seitenzahl: 235
• Erscheinungstermin: 11. Juni 2024
• Englisch
• ISBN-13: 9781682193525
• Artikelnr.: 64183675

Autorenporträt

Bruce Ratner has led an eclectic life. After focusing much of his undergraduate coursework on math, biology, and physics, he started his career in law and public service as an assistant professor at New York University Law School and Commissioner of Consumer Affairs under Mayor Ed Koch. In his late 30s, he moved into real estate, becoming one of the city's largest developers. Over the course of three decades, his firm developed some of New York's most prominent buildings and fostered the renaissance of the borough of Brooklyn.

In 2016, Ratner's brother, Michael, died of metastatic cancer. Through this tragedy, Ratner came to see that there were scarcely any cures for most advanced cancers, despite headlines regularly implying otherwise. Instead, he realized that early detection was the key to reducing cancer mortality. Following his brother's death, he founded a non-profit, the Michael D. Ratner Center for Early Detection of Cancer, to research and promote better cancer screening. He is on the boards of Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, and the Cold Spring Harbor Laboratory.

Adam Bonislawski is a science writer with ten-plus years of experience covering genomic and proteomic research and diagnostics development with a focus on cancer diagnostics and early detection. He has written hundreds of articles on cancer early detection, covering everything from cutting edge academic research to established companies and technologies and looking at the full range of challenges, from scientific to organizational to financial to societal, involved in developing and implementing new tests for cancer. The publications he writes for, GenomeWeb and 360Dx, are read by thousands of cancer researchers and doctors as well as a wide range of healthcare entrepreneurs and investors, and he has scientific and media contacts at many of the major cancer and academic research centers in the United States and Europe.